☰

Zohreh Amoozgar, Ph.D. - Publications

Affiliations: 
2011 Industrial and Physical Pharmacy Purdue University, West Lafayette, IN, United States 
Area:
Pharmacy, Biomedical Engineering
Tree Info Similar researchers PubMed Report error

26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Mahmudi H, Adili-Aghdam MA, Shahpouri M, Jaymand M, Amoozgar Z, Jahanban-Esfahlan R. Tumor microenvironment penetrating chitosan nanoparticles for elimination of cancer relapse and minimal residual disease. Frontiers in Oncology. 12: 1054029. PMID 36531004 DOI: 10.3389/fonc.2022.1054029  0.321
2020 Dianat-Moghadam H, Heidarifard M, Mahari A, Shahgolzari M, Keshavarz M, Nouri M, Amoozgar Z. TRAIL in oncology: From recombinant TRAIL to nano- and self-targeted TRAIL-based therapies. Pharmacological Research. 104716. PMID 32084560 DOI: 10.1016/J.Phrs.2020.104716  0.369
2019 Amoozgar Z, Jain RK, Duda DG. Role of Apelin in Glioblastoma Vascularization and Invasion after Anti-VEGF Therapy: What Is the Impact on the Immune System? Cancer Research. 79: 2104-2106. PMID 31043429 DOI: 10.1158/0008-5472.Can-19-0749  0.319
2018 Cremasco V, Astarita JL, Grauel AL, Keerthivasan S, MacIsaac KD, Woodruff MC, Wu M, Spel L, Santoro S, Amoozgar Z, Laszewski T, Cruz-Migoni S, Knoblich K, Fletcher AL, LaFleur M, et al. FAP delineates heterogeneous and functionally divergent stromal cells in immune-excluded breast tumors. Cancer Immunology Research. PMID 30266714 DOI: 10.1158/2326-6066.Cir-18-0098  0.355
2018 Fukumura D, Kloepper J, Amoozgar Z, Duda DG, Jain RK. Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges. Nature Reviews. Clinical Oncology. PMID 29508855 DOI: 10.1038/Nrclinonc.2018.29  0.316
2018 Dixon KO, Schorer M, Nevin J, Etminan Y, Amoozgar Z, Kondo T, Kurtulus S, Kassam N, Sobel RA, Fukumura D, Jain RK, Anderson AC, Kuchroo VK, Joller N. Functional Anti-TIGIT Antibodies Regulate Development of Autoimmunity and Antitumor Immunity. Journal of Immunology (Baltimore, Md. : 1950). PMID 29500245 DOI: 10.4049/Jimmunol.1700407  0.304
2016 Kloepper J, Riedemann L, Amoozgar Z, Seano G, Susek K, Yu V, Dalvie N, Amelung RL, Datta M, Song JW, Askoxylakis V, Taylor JW, Lu-Emerson C, Batista A, Kirkpatrick ND, et al. Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival. Proceedings of the National Academy of Sciences of the United States of America. PMID 27044098 DOI: 10.1073/Pnas.1525360113  0.347
2016 Peterson TE, Kirkpatrick ND, Huang Y, Farrar CT, Marijt KA, Kloepper J, Datta M, Amoozgar Z, Seano G, Jung K, Kamoun WS, Vardam T, Snuderl M, Goveia J, Chatterjee S, et al. Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages. Proceedings of the National Academy of Sciences of the United States of America. PMID 27044097 DOI: 10.1073/Pnas.1525349113  0.342
2016 Abolmaali SS, Tamaddon AM, Mohammadi S, Amoozgar Z, Dinarvand R. Chemically crosslinked nanogels of PEGylated poly ethyleneimine (l-histidine substituted) synthesized via metal ion coordinated self-assembly for delivery of methotrexate: Cytocompatibility, cellular delivery and antitumor activity in resistant cells. Materials Science & Engineering. C, Materials For Biological Applications. 62: 897-907. PMID 26952497 DOI: 10.1016/J.Msec.2016.02.045  0.336
2016 Cremasco V, Grauel A, Wu M, Astarita J, Woodruff M, Amoozgar Z, Spel L, Brown F, Carroll M, MacIsaac K, Dranoff G, Turley S. Abstract IA23: Microenvironmental regulation of antitumor immune responses: A lesson from fibroblastic cells Cancer Immunology Research. 4. DOI: 10.1158/2326-6066.Imm2016-Ia23  0.387
2016 Kloepper J, Riedemann L, Amoozgar Z, Seano G, Susek KH, Yu V, Dalvie N, Amelung RL, Datta M, Song JW, Askoxylakis V, Taylor JW, Lu-Emerson C, Batista A, Kirkpatrick ND, et al. Abstract LB-347: Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-347  0.37
2016 Amoozgar Z, Peterson TE, Kirkpatrick ND, Huang Y, Farrar CT, Marijt KA, Kloepper J, Datta M, Seano G, Jung K, Kamoun WS, Vardam T, Snuderl M, Goveia J, Chatterjee S, et al. Abstract LB-346: Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-346  0.355
2016 Peterson T, Kirkpatrick N, Huang Y, Farrar C, Marjit K, Kloepper J, Datta M, Amoozgar Z, Seano G, Jung K, Kamoun W, Vardam T, Snuderl M, Goveia J, Chatterjee S, et al. Tmic-07. Dual Inhibition Of Ang-2 And Vegf Receptors Normalizes Tumor Vasculature And Prolongs Survival In Glioblastoma By Altering Macrophages Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now212.847  0.306
2016 Riedemann L, Kloepper J, Amoozgar Z, Seano G, Susek K, Yu V, Dalvie N, Amelung R, Datta M, Song JW, Askoxylakis V, Taylor J, Lu-Emerson C, Batista A, Kirkpatrick N, et al. IMST-40. REPROGRAMMING OF THE TUMOR IMMUNE MICROENVIRONMENT BY AN ANG-2/VEGF BISPECIFIC ANTIBODY DELAYS TUMOR GROWTH AND PROLONGS SURVIVAL IN PRECLINICAL GBM MODELS Neuro-Oncology. 18: vi95-vi95. DOI: 10.1093/Neuonc/Now212.396  0.333
2015 Wang L, Amoozgar Z, Huang J, Saleh MH, Xing D, Orsulic S, Goldberg MS. Decitabine enhances lymphocyte migration and function and synergizes with CTLA-4 blockade in a murine ovarian cancer model. Cancer Immunology Research. PMID 26056145 DOI: 10.1158/2326-6066.Cir-15-0073  0.328
2015 Huang J, Wang L, Cong Z, Amoozgar Z, Kiner E, Xing D, Orsulic S, Matulonis U, Goldberg MS. The PARP1 inhibitor BMN 673 exhibits immunoregulatory effects in a Brca1(-/-) murine model of ovarian cancer. Biochemical and Biophysical Research Communications. 463: 551-6. PMID 26047697 DOI: 10.1016/J.Bbrc.2015.05.083  0.335
2015 Park CG, Shasteen C, Amoozgar Z, Park J, Kim SN, Lee JE, Lee MJ, Suh Y, Seok HK, Yeo Y, Choy YB. Photo-crosslinkable chitosan hydrogel as a bioadhesive for esophageal stents Macromolecular Research. DOI: 10.1007/S13233-015-3115-0  0.485
2014 Amoozgar Z, Goldberg MS. Targeting myeloid cells using nanoparticles to improve cancer immunotherapy. Advanced Drug Delivery Reviews. PMID 25280471 DOI: 10.1016/J.Addr.2014.09.007  0.401
2014 Amoozgar Z, Wang L, Brandstoetter T, Wallis SS, Wilson EM, Goldberg MS. Dual-layer surface coating of PLGA-based nanoparticles provides slow-release drug delivery to achieve metronomic therapy in a paclitaxel-resistant murine ovarian cancer model. Biomacromolecules. 15: 4187-94. PMID 25251833 DOI: 10.1021/Bm5011933  0.39
2013 Amoozgar Z, Park J, Lin Q, Weidle JH, Yeo Y. Development of quinic acid-conjugated nanoparticles as a drug carrier to solid tumors. Biomacromolecules. 14: 2389-95. PMID 23738975 DOI: 10.1021/Bm400512G  0.556
2012 Amoozgar Z, Park J, Lin Q, Yeo Y. Low molecular-weight chitosan as a pH-sensitive stealth coating for tumor-specific drug delivery. Molecular Pharmaceutics. 9: 1262-70. PMID 22489704 DOI: 10.1021/Mp2005615  0.56
2012 Amoozgar Z, Rickett T, Park J, Tuchek C, Shi R, Yeo Y. Semi-interpenetrating network of polyethylene glycol and photocrosslinkable chitosan as an in-situ-forming nerve adhesive. Acta Biomaterialia. 8: 1849-58. PMID 22310507 DOI: 10.1016/J.Actbio.2012.01.022  0.539
2012 Amoozgar Z, Yeo Y. Recent advances in stealth coating of nanoparticle drug delivery systems. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. 4: 219-33. PMID 22231928 DOI: 10.1002/Wnan.1157  0.536
2011 Rickett TA, Amoozgar Z, Tuchek CA, Park J, Yeo Y, Shi R. Rapidly photo-cross-linkable chitosan hydrogel for peripheral neurosurgeries. Biomacromolecules. 12: 57-65. PMID 21128673 DOI: 10.1021/Bm101004R  0.551
2010 Rask F, Dallabrida SM, Ismail NS, Amoozgar Z, Yeo Y, Rupnick MA, Radisic M. Photocrosslinkable chitosan modified with angiopoietin-1 peptide, QHREDGS, promotes survival of neonatal rat heart cells. Journal of Biomedical Materials Research. Part A. 95: 105-17. PMID 20540095 DOI: 10.1002/Jbm.A.32808  0.524
2009 Rickett T, Amoozgar Z, Sun W, Yeo Y, Shi R. A photo-crosslinkable chitosan hydrogel for peripheral nerve anastomosis Proceedings of the 2009 2nd International Conference On Biomedical Engineering and Informatics, Bmei 2009. DOI: 10.1109/BMEI.2009.5305460  0.512
Show low-probability matches.